From: Defining the optimal dose of radiation in leukemic patients with extramedullary lesions
Factors ( 2 × 2 analysis) | Response (CR + PR) | Non-response (SD + PD) | Total | p -value | |
---|---|---|---|---|---|
Primary disease | Yes | 23 | 4 | 27 | 0.128 |
AML | No | 9 | 6 | 15 | Â |
RT site | Yes | 14 | 2 | 16 | 0.270 |
Soft tissue | No | 18 | 8 | 26 | Â |
Concurrent | Yes | 8 | 1 | 9 | 1.000 |
Chemotherapy | No | 24 | 9 | 33 | Â |
Initial size | Yes | 13 | 9 | 22 | 0.010* |
BP ≥ 10 cm2 | No | 19 | 1 | 20 |  |
Initial size | Yes | 14 | 7 | 21 | 0.277 |
LD ≥ 6.0 cm | No | 18 | 3 | 21 |  |
Follow up time | Yes | 23 | 7 | 30 | 1.000 |
≥ 2 weeks | No | 9 | 3 | 12 |  |
Total dose | Yes | 16 | 1 | 17 | 0.031* |
≥ 25 Gy | No | 16 | 9 | 25 |  |
BED10 | Yes | 17 | 1 | 18 | 0.026* |
≥ 30 Gy | No | 15 | 9 | 24 |  |